LPAL2 Protein, Human, Recombinant (mFc)

Ref. TM-TMPY-04124

Informations sur le produit

• Nom: LPAL2 Protein, Human, Recombinant (mFc)
• Synonymes: APOARGC, APOAL, lipoprotein, Lp(a)-like 2, pseudogene, LPAL2, APOA2, apo(a)rg-C

Description

LPAL2 (Lipoprotein(A) Like 2, Pseudogene) is a Pseudogene. This gene is similar to the lipoprotein, Lp(a) gene, but all transcripts produced by this gene contain a truncated open reading frame and are candidates for nonsense-mediated decay. Lipoprotein(a) [Lp(a)] level is an established risk factor for coronary artery disease and has been implicated in carotid artery disease (CAAD). Mutations in the solute carrier family 22 member 3 (SLC22A3), lipoprotein (a)-like 2 (LPAL2), and the lipoprotein (a) (LPA) gene cluster, which encodes apolipoprotein (a) [apo (a)] of the lipoprotein (a) [Lp (a)] lipoprotein particle, have been suggested to contribute to the risk of coronary artery disease (CAD). Recent genome-wide association studies have identified that genetic variants in the SLC22A3-LPAL2-LPA gene cluster influence plasma lipoprotein(a) [Lp(a)] concentration.

• Marque: Targetmol

Propriétés chimiques

• Masse moléculaire: 38.9 kDa (predicted)
• Couleur/Forme: Solid